Advertisement
Product Releases
Advertisement

Device Assesses Oxygen Delivery To Tissue

Fri, 10/22/2010 - 6:28am

LISTED UNDER:

Spectros offers advanced molecular sensing devices that shed light on life-threatening diseases, including ischemia and cancer. The medical devices build upon optical molecular technologies to speed diagnosis, reduce complications and lower costs.

Spectros offers advanced molecular sensing devices that shed light on life-threatening diseases, including ischemia and cancer. The medical devices build upon optical molecular technologies to speed diagnosis, reduce complications and lower costs. The company’s T-Stat is a device to be labeled by the FDA as “sensitive to Ischemia” and has been proven in multiple trials as an easy-to-use and reliable tool for assessing the adequacy of oxygen delivery to tissue. According to the company, the T-Stat 303 features:

  • A continuous, non-invasive and localized measurement, sensitive to regional and global ischemia.
  • The ability to report a capillary-weighted oxygen saturation which is closely related to a local venous saturation.
  • The complete Spectros monitoring systems consists of the T-Stat 303 monitor and any of 5 single use probes designed for specific applications and measurement sites.
  • Each probe contains a visible white light source for illuminating the tissue and a fiber optic bundle that transmits directly back to the monitor for real-time results.

For further information, visit our www.spectros.com

 

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading